All lobbying filings

THORN RUN PARTNERS

Lobbying for ALKERMES, INC. · biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $50,000.00 income · posted Jul 16, 2025

Official filing document

Bills named in this filing 1

SCONRES 14
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 an…

Lobbying activity 2

Health Issues

Implementation of the Comprehensive Addiction and Recovery Act of 2016, P.L.114-198. Issues related to the opioid and mental illness epidemic, Commerce, State, Justice, and Labor, Health and Human Services Appropriations.

Medicare/Medicaid

Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.